CLBS Caladrius Biosciences, Inc. Stock Quote

CLBS [NASD]

Index	-	P/E	-	EPS (ttm)	-0.63	Insider Own	1.70%	Shs Outstand	19.41M	Perf Week	-13.90%
Market Cap	120.38M	Forward P/E	-	EPS next Y	-0.41	Insider Trans	5.50%	Shs Float	15.99M	Perf Month	-5.88%
Income	-7.70M	PEG	-	EPS next Q	-0.08	Inst Own	7.20%	Short Float	9.08%	Perf Quarter	32.41%
Sales	-	P/S	-	EPS this Y	56.90%	Inst Trans	11.70%	Short Ratio	0.27	Perf Half Y	0.52%
Book/sh	1.67	P/B	1.15	EPS next Y	40.70%	ROA	-	Target Price	-	Perf Year	-25.29%
Cash/sh	0.55	P/C	3.48	EPS next 5Y	-	ROE	-	52W Range	1.05 - 4.89	Perf YTD	34.27%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-60.74%	Beta	1.22
Dividend %	-	Quick Ratio	10.10	Sales past 5Y	-	Gross Margin	-	52W Low	82.86%	ATR	0.34
Employees	27	Current Ratio	10.10	Sales Q/Q	-	Oper. Margin	-	RSI (14)	45.83	Volatility	15.09% 12.65%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.53	Prev Close	1.92
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Feb 25 AMC	Payout	-	Avg Volume	5.42M	Price	1.92
Recom	2.30	SMA20	-12.65%	SMA50	-0.00%	SMA200	1.68%	Volume	0	Change	0.00%

May-18-20

Downgrade

Dawson James

Buy → Neutral

Nov-20-18

Resumed

H.C. Wainwright

Buy

$18.50

Aug-23-16

Initiated

Chardan Capital Markets

Buy

$6.50

Apr-29-16

Upgrade

H.C. Wainwright

Neutral → Buy

$1.25

Jan-08-16

Downgrade

H.C. Wainwright

Buy → Neutral

Jan-07-16

Downgrade

Maxim Group

Buy → Hold

Dec-22-15

Reiterated

Maxim Group

Buy

$12 → $4

Feb-25-21 04:05PM	Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update GlobeNewswire -9.91%
02:30PM	Caladrius Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Feb-18-21 04:05PM	Caladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time GlobeNewswire -7.59%
08:30AM	Longeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate Finance Executives to the Board of Directors GlobeNewswire
Feb-17-21 01:59PM	Caladrius Biosciences, Inc. Closes $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules GlobeNewswire
Feb-12-21 08:15AM	Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules GlobeNewswire -14.65%
Jan-25-21 05:05PM	Caladrius Biosciences Closes $25.0 Million Private Placement GlobeNewswire
08:30AM	Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021 GlobeNewswire
Jan-21-21 09:00AM	Caladrius Biosciences Announces $25.0 Million Private Placement GlobeNewswire -13.49%
Jan-20-21 02:25PM	Is Caladrius Stock a Buy Right Now? This Is What You Need to Know TipRanks +77.30%
Jan-19-21 08:00AM	Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction GlobeNewswire
Jan-06-21 08:30AM	Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021 GlobeNewswire
Dec-14-20 08:29AM	Virtual Conference for Life Sciences Companies Broadcast Live December 17th, 2020 GlobeNewswire -11.59%
08:00AM	Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update GlobeNewswire
Dec-10-20 08:30AM	Caladrius Biosciences to Webcast Live at Life Sciences Investor Forum GlobeNewswire +7.14%
Dec-09-20 04:05PM	Caladrius Biosciences to Present at the 13th Annual LD Micro Main Event Conference GlobeNewswire
Nov-29-20 08:15PM	Is Caladrius Biosciences Inc (CLBS) A Good Stock To Buy? Insider Monkey
Nov-17-20 04:05PM	Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical Officer GlobeNewswire
Nov-10-20 08:30AM	Caladrius Biosciences to Present at American Heart Associations Virtual Scientific Sessions 2020 GlobeNewswire
Nov-05-20 04:05PM	Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results GlobeNewswire
02:15PM	Caladrius Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Nov-04-20 08:30AM	Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in November GlobeNewswire
Nov-02-20 08:30AM	Caladrius Biosciences Appoints Industry Veteran, Anne Whitaker, to Board of Directors GlobeNewswire
Oct-29-20 08:30AM	Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time GlobeNewswire
Oct-21-20 08:30AM	Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360° GlobeNewswire
Oct-17-20 09:14AM	Caladrius Biosciences (NASDAQ:CLBS) Is In A Good Position To Deliver On Growth Plans Simply Wall St.
Oct-08-20 08:00AM	Caladrius Biosciences Opens Study of CLBS119 to Repair COVID-19-Induced Lung Damage GlobeNewswire
Oct-07-20 04:05PM	Caladrius Biosciences to Present at the Alliance for Regenerative Medicines Virtual Cell and Gene Meeting on the Mesa GlobeNewswire
Oct-06-20 04:05PM	Caladrius Biosciences to Present at the BIO Investor Forum Digital GlobeNewswire
Sep-21-20 08:35AM	Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing GlobeNewswire
Sep-14-20 08:35AM	Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020 GlobeNewswire
Sep-10-20 08:00AM	Caladrius Biosciences to Participate in Landmarks 10th Annual Investing for Cures Virtual Forum GlobeNewswire
Sep-09-20 08:00AM	Caladrius Biosciences Announces Registration of HONEDRA® Trademark and New Patent in Japan GlobeNewswire
Sep-08-20 08:00AM	Caladrius Biosciences to Present at H.C. Wainwright 22nd Annual Global Investment Virtual Conference GlobeNewswire +6.88%
Sep-03-20 08:00AM	Caladrius Biosciences to Participate in the Advanced Therapies Congress & Expo 2020 GlobeNewswire -7.07%
Sep-01-20 04:34PM	LD Micro: 360 Companies--Set to Present this Week. ACCESSWIRE
Aug-27-20 08:00AM	Caladrius Biosciences to Present at the LD 500 Virtual Conference on September 1, 2020 at 11:40 AM Eastern Time ACCESSWIRE
Aug-13-20 04:05PM	Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results GlobeNewswire
Aug-06-20 08:30AM	Caladrius Biosciences to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 13, 2020 GlobeNewswire -10.38%
Aug-05-20 04:05PM	Caladrius Biosciences Announces the Resignation of Joseph Talamo, Chief Financial Officer GlobeNewswire +6.12%
11:15AM	LD Micro - Announces Preliminary List of Presenters for the LD-500. ACCESSWIRE
Jul-28-20 08:00AM	Caladrius Biosciences Appoints Dr. Michael H. Davidson to Board of Directors GlobeNewswire -7.66%
Jun-02-20 08:06AM	Caladrius Biosciences to Present on CLBS119 for COVID-19 Induced Lung Damage at the BioNJ COVID-19 Rapid Fire Research Showcase GlobeNewswire
May-28-20 01:20PM	Caladrius Biosciences Closes $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules GlobeNewswire
May-26-20 08:00AM	Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules GlobeNewswire -15.87%
May-14-20 03:42PM	Caladrius Biosciences Reports Positive Full Results for CLBS16 from the ESCaPE-CMD Trial at SCAI 2020 Scientific Sessions GlobeNewswire -21.30%
May-13-20 12:16AM	Edited Transcript of CLBS earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-12-20 11:15AM	Simple Market Timing Strategies That Work - May 12, 2020 Zacks +8.78%
May-07-20 04:05PM	Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results GlobeNewswire
May-06-20 08:30AM	Caladrius Biosciences Announces Presentation of Full Results for CLBS16 from the ESCaPE-CMD Trial at SCAI 2020 Scientific Sessions GlobeNewswire
Apr-30-20 08:30AM	Caladrius Biosciences to Host First Quarter 2020 Financial Results Conference Call on Thursday, May 7, 2020 GlobeNewswire
Apr-27-20 03:16PM	Caladrius Biosciences Closes $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules GlobeNewswire -5.33%
Apr-23-20 02:00PM	Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules GlobeNewswire
08:55AM	Caladrius Biosciences Plans to Assess its CLBS119 Cell Therapy for Repair of COVID-19 Induced Lung Damage GlobeNewswire
Apr-22-20 08:00AM	Caladrius Biosciences to Receive $10.9 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program GlobeNewswire
Apr-20-20 07:14AM	We're Keeping An Eye On Caladrius Biosciences's (NASDAQ:CLBS) Cash Burn Rate Simply Wall St.
Mar-26-20 10:17AM	Edited Transcript of CLBS earnings conference call or presentation 5-Mar-20 9:30pm GMT Thomson Reuters StreetEvents
Mar-17-20 07:00AM	Memgen Appoints Gregory Brown as Chief Executive Officer Newsfile -12.07%
Mar-06-20 09:22AM	The Truth About Market Timing - March 06, 2020 Zacks
Mar-05-20 04:05PM	Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update GlobeNewswire
02:30PM	Caladrius Biosciences, Inc. to Host Earnings Call ACCESSWIRE
Feb-27-20 08:30AM	Caladrius Biosciences to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Thursday, March 5, 2020 at 4:30 p.m. Eastern Time GlobeNewswire -8.93%
Feb-03-20 08:30AM	Caladrius Biosciences to Participate at Upcoming February Conferences GlobeNewswire
Jan-27-20 09:17AM	The Market Timing Secrets No One Talks About - January 27, 2020 Zacks
Jan-21-20 07:35AM	Does Caladrius Biosciences, Inc. (NASDAQ:CLBS) Have A Particularly Volatile Share Price? Simply Wall St.
Jan-07-20 04:05PM	Caladrius Biosciences to Participate at Upcoming January Conferences GlobeNewswire
10:00AM	Simple Market Timing Strategies That Work - January 07, 2020 Zacks
Dec-02-19 04:05PM	Caladrius Biosciences to Participate at Upcoming December Conferences GlobeNewswire -7.14%
Nov-25-19 08:56AM	Timing the Market, Is it Possible? - November 25, 2019 Zacks
Nov-19-19 05:56PM	Edited Transcript of CLBS earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-16-19 03:59PM	Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019 GlobeNewswire
Nov-06-19 04:05PM	Caladrius Biosciences Reports 2019 Third Quarter and Nine Month Financial Results and Provides Corporate Update GlobeNewswire
Nov-04-19 08:44AM	When Does Market Timing Actually Work? - November 04, 2019 Zacks
Oct-31-19 08:30AM	Caladrius Biosciences to Participate at Upcoming November Conferences GlobeNewswire
Oct-30-19 08:30AM	Caladrius Biosciences to Host 2019 Third Quarter Financial Results and Business Update Conference Call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern Time GlobeNewswire
Oct-23-19 11:30AM	Is Caladrius Biosciences (NASDAQ:CLBS) In A Good Position To Deliver On Growth Plans? Simply Wall St. +5.86%
Oct-14-19 11:58AM	Edited Transcript of CLBS earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents +8.96%
08:36AM	The Market Timing Secrets No One Talks About - October 14, 2019 Zacks
Oct-01-19 08:30AM	Caladrius Biosciences to Participate at the Upcoming October Conferences GlobeNewswire
Sep-24-19 09:04AM	The Keys to Successfully Timing the Markets - September 24, 2019 Zacks
Sep-06-19 10:15AM	CORRECTING and REPLACING -- Caladrius Biosciences to Participate at the Upcoming September Conferences GlobeNewswire
Sep-05-19 04:05PM	Caladrius Biosciences to Participate at the Upcoming September Conferences GlobeNewswire
Sep-04-19 08:58AM	The Keys to Successfully Timing the Markets - September 04, 2019 Zacks
Aug-15-19 09:57AM	The Keys to Successful Timing the Markets - August 15, 2019 Zacks
Aug-08-19 04:05PM	Caladrius Biosciences Reports 2019 Second Quarter and First Six Months Financial Results and Provides Corporate Update GlobeNewswire
Aug-07-19 08:30AM	Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14 in No-option Refractory Disabling Angina GlobeNewswire
Aug-05-19 10:55AM	Top Ranked Momentum Stocks to Buy for August 5th Zacks
Aug-01-19 08:30AM	Caladrius Biosciences to Host 2019 Second Quarter Financial Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. Eastern Time GlobeNewswire
Jul-25-19 03:04PM	If You Had Bought Caladrius Biosciences (NASDAQ:CLBS) Stock Five Years Ago, You'd Be Sitting On A 95% Loss, Today Simply Wall St.
11:27AM	Top Ranked Momentum Stocks to Buy for July 25th Zacks
Jul-15-19 08:30AM	Caladrius Biosciences Receives Advanced Therapy Medicinal Product Classification for CLBS12, its CD34+ Cell Therapy for Critical Limb Ischemia GlobeNewswire +11.79%
Jun-04-19 08:30AM	Caladrius Biosciences Completes Enrollment in Phase 2 ESCaPE-CMD Trial for Coronary Microvascular Dysfunction GlobeNewswire
May-24-19 03:53AM	Edited Transcript of CLBS earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-09-19 04:05PM	Caladrius Biosciences Reports 2019 First Quarter Financial Results and Provides Corporate Update GlobeNewswire
May-07-19 08:30AM	Caladrius Biosciences to Participate at the Upcoming May Conferences GlobeNewswire
May-02-19 08:30AM	Caladrius Biosciences to Host 2019 First Quarter Financial Results Conference Call on Thursday, May 9, 2019 at 4:30 p.m. Eastern Time GlobeNewswire
Apr-25-19 02:23PM	How Does Caladrius Biosciences, Inc. (NASDAQ:CLBS) Affect Your Portfolio Volatility? Simply Wall St.
Apr-03-19 08:30AM	Caladrius Biosciences to Participate in Upcoming Conferences GlobeNewswire
Mar-14-19 04:23PM	Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results ACCESSWIRE
04:20PM	Caladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 million ACCESSWIRE

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, develops cellular therapeutic product candidates to address diseases and conditions caused by ischemia. Its product candidates include developmental treatments for cardiovascular diseases, such as CLBS12 for the treatment of critical limb ischemia; CLBS16, which is in Phase II clinical trial for the treatment of coronary microvascular dysfunction; CLBS14, a regenerative medicine advanced therapy for treating no-option refractory disabling angina. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was founded in 1980 and is headquartered in Basking Ridge, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Davidson Michael H.	Director	Sep 09	Buy	1.80	55,525	99,945	106,588	Sep 10 04:01 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience